News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
Mind Medicine (MindMed)
Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality
Field Trip Health
Blackhawk Growth Fully Funds Phase II Clinical Trials in Psychedelics and Begins Development of Digital Mental Health Treatments
MindBio Therapeutics
Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
Wellbeing Digital Sciences
Lobe Sciences Announces That Its Shares Will Trade on the OTCQB(R) Market in the United States
Lobe Sciences
HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes
Havn Life
Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives
Mydecine Innovations Group
MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System
Mind Medicine (MindMed)
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
Algernon Pharmaceuticals
Ketamine One Adds Seattle Location To US Clinical Network
Wellbeing Digital Sciences
Mydecine Files Full Patent Application Covering Multiple Families of Psilocin Analogs
Mydecine Innovations Group
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.